×

Penalized likelihood ratio test for a biomarker threshold effect in clinical trials based on generalized linear models. (English. French summary) Zbl 07759526

Summary: In a clinical trial, the responses to the new treatment may vary among patient subsets with different characteristics in a biomarker. It is often necessary to examine whether there is a cutpoint for the biomarker that divides the patients into two subsets of those with more favourable and less favourable responses. More generally, we approach this problem as a test of homogeneity in the effects of a set of covariates in generalized linear regression models. The unknown cutpoint results in a model with nonidentifiability and a nonsmooth likelihood function to which the ordinary likelihood methods do not apply. We first use a smooth continuous function to approximate the indicator function defining the patient subsets. We then propose a penalized likelihood ratio test to overcome the model irregularities. Under the null hypothesis, we prove that the asymptotic distribution of the proposed test statistic is a mixture of chi-squared distributions. Our method is based on established asymptotic theory, is simple to use, and works in a general framework that includes logistic, Poisson, and linear regression models. In extensive simulation studies, we find that the proposed test works well in terms of size and power. We further demonstrate the use of the proposed method by applying it to clinical trial data from the Digitalis Investigation Group (DIG) on heart failure.
{© 2022 Statistical Society of Canada}

MSC:

62-XX Statistics
Full Text: DOI

References:

[1] Bickel, P. J. & Chernoff, H. (1993). Asymptotic distribution of the likelihood ratio statistic in a prototypical non‐regular problem. In Ghosh, J. K. (ed.), Mitra, S. K. (ed.), Parthasarathy, K. R. (ed.), & Prakasa Rao, B. L. S. (ed.) (Eds.), Statistics and Probability: A Raghu Raj Bahadur Festschrift, Wiley, New York, NY, 83-96.
[2] Chen, B. E. (2021). An R package for the biomarker threshold models version 1.17. https://CRAN.R‐project.org/package=bhm
[3] Chen, B. E., Jiang, W., & Tu, D. (2014). A hierarchical Bayes model for biomarker subset effects in clinical trials. Computational Statistics and Data Analysis, 71, 324-334. · Zbl 1471.62038
[4] Chen, H., Chen, J., & Kalbfleish, J. D. (2001). A modified likelihood ratio test for homogeneity in the finite mixture models. Journal of the Royal Statistical Society, Series B (Statistical Methodology), 63(1), 19-29. · Zbl 0976.62011
[5] Chen, J. (1995). Optimal rate of convergence in finite mixture models. Annals of Statistics, 23(1), 221-233. · Zbl 0821.62023
[6] Chen, J. (1998). Penalized likelihood ratio test for finite mixture models with multinomial observations. The Canadian Journal of Statistics, 26(4), 583-599. · Zbl 1066.62509
[7] Davies, R. B. (1977). Hypothesis testing when a nuisance parameter is present only under the alternative. Biometrika, 64(2), 247-254. · Zbl 0362.62026
[8] Davies, R. B. (1987). Hypothesis testing when a nuisance parameter is present only under the alternative. Biometrika, 74(1), 33-43. · Zbl 0612.62023
[9] Fang, T., Mackillop, W., Jiang, W., Hildesheim, A., Wacholder, S., & Chen, B. E. (2017). A Bayesian method for risk window estimation with application to HPV vaccine trial. Computational Statistics and Data Analysis, 112, 53-62. · Zbl 1464.62067
[10] Feng, Z. D. & McCulloch, C. E. (1996). Using bootstrap likelihood ratios in finite mixture models. Journal of the Royal Statistical Society, Series B (Statistical Methodology), 58, 609-617. · Zbl 0906.62021
[11] Garg, R., Gorlin, R., Smith, T., & Yusuf, S. (1997). The effect of Digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine, 336(8), 525-533.
[12] Gavanji, P., Chen, B. E., & Jiang, W. (2018). Residual bootstrap test for interactions in biomarker threshold models with survival data. Statistics in Bioscience, 10, 202-216.
[13] Ghosh, J. K. & Sen, P. K. (1985). On the asymptotic performance of the log likelihood ratio statistic for the mixture model and related results. In LeCam, L. (ed.) & Olshen, R. A. (ed.) (Eds.), Proceedings of Berkeley Conference in Honor of Jerzy Neyman and Jack Kiefer, Vol. 2, Wadsworth, Inc., Monterey, CA, 789-806. · Zbl 1373.62075
[14] Hartigan, J. A. (1985). A failure of likelihood asymptotics for normal mixtures. In LeCam, L. (ed.) & Olshen, R. A. (ed.) (Eds.), Proceedings of Berkeley Conference in Honor of Jerzy Neyman and Jack Kiefer, Vol. 2, Wadsworth, Inc., Monterey, CA, 807-810. · Zbl 1373.62070
[15] Jiang, W., Freidlin, B., & Simon, R. (2007). Biomarker‐adaptive threshold design: A procedure for evaluating treatment with possible biomarker‐defined subset effect. Journal of National Cancer Institute, 99(3), 1036-1043.
[16] Li, P., Chen, J., & Marriott, P. (2009). Non‐finite Fisher information and homogeneity: An EM approach. Biometrika, 96(2), 411-442. · Zbl 1163.62012
[17] Lindsay, B. G. (1995). Mixture Models: Theory, Geometry, and Applications, CBNMS‐NSF Regional Conference Series in Probability and Statistics, SIAM, Philadelphia, PA. · Zbl 1163.62326
[18] McLachlan, G. J. (1987). On bootstrapping the likelihood ratio test statistic for the number of components in a normal mixture. Applied Statistics, 36(3), 318-324.
[19] Satterthwaite, F. E. (1941). Synthesis of variance. Psychometrika, 6, 309-316. · Zbl 0063.06742
[20] Shen, J. & He, X. (2015). Inference for subgroup analysis with a structured logistic‐normal mixture model. Journal of the American Statistical Association, 110, 303-312. · Zbl 1373.62078
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.